IGF-1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors

Triple-negative breast cancers (TNBC) are an aggressive disease subtype which unlike other subtypes lack an effective targeted therapy. Inhibitors of the insullin-like growth factor receptor (IGF-1R) have been considered for use in treating TNBC. Here we provide genetic evidence that IGF-1R inhibiti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Res
Huvudupphovsmän: Rota, Lauren M., Albanito, Lidia, Shin, Marcus E., Goyeneche, Corey L., Shushanov, Sain, Gallagher, Emily J., LeRoith, Derek, Lazzarino, Deborah A., Wood, Teresa L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782979/
https://ncbi.nlm.nih.gov/pubmed/25092896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-0970
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk